Heron Therapeutics, Inc. (HRTX)
$0.32+0.00%Close
SELLCRISIS · day 11
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $51M
- Avg volume
- 3.2M
- Beta
- 1.67
- P/E (TTM)
- -1.72
- Short % float
- 32.73%
- Days to cover
- 24.4
- SI change
- +1.4%
- 1W
- +0.00%
- 1M
- -30.43%
- 3M
- -62.79%
- YTD
- -74.60%
- vs SPY 1W
- +1.19%
- vs SPY 1M
- -33.76%
- vs SPY 3M
- -65.18%
- vs SPY YTD
- -86.36%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- PROFSELLProfound Medical Corp.RECOVERYQ 13$6.80+0.15%
- SILOSELLSilo Pharma, Inc.CRISISQ -2$2.58-2.64%
- TLSIBUYTriSalus Life Sciences, Inc.RECOVERYQ -6$5.11-3.04%
- AIDXBUY20/20 Biolabs Inc.Q -45$0.52-5.45%
- CSCIBUYCOSCIENS Biopharma Inc.RECOVERYQ -7$2.72+0.00%
- MDAISELLSpectral AI, Inc.RECOVERYQ -12$1.60+0.00%
- CNSYBUYCRISISQ -11$2.96-3.58%
- VTVTBUYvTv Therapeutics Inc.RECOVERYQ 3$33.89+1.89%
- FOCLSELLCRISISQ 13$4.18+1.21%
- AQSTBUYAquestive Therapeutics, Inc.RECOVERYQ -4$4.80+3.00%
- ALMRBUYAlamar Biosciences, Inc.Q 83$32.70-4.50%
- NRSNSELLNeuroSense Therapeutics Ltd.CRISISQ -6$0.38+0.00%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 8
- VALUE
- 0
- GROWTH
- 36
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-180.5%
REV YoY-
ROE-300.9%
EPS YoY-
ROA-13.5%
GROSS70
OP-7
NET-23
[VALUATION]
P/E TTM-1.72
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B8.89
P/FCF-
EV/EBITDA-6.78
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E2147.57
ALTMAN Z-
CURR RATIO2.49
ND/EBITDA-
BETA1.67
